A trial looking at T4 immunotherapy for people with head and neck cancer

Please note

This trial is no longer recruiting patients. We hope to add results when they are available.

Overview

Cancer types:

Head and neck cancers

Status:

Closed

Phase:

Phase 1

Details

This trial is looking at using T4 immunotherapy for people with head and neck cancer who have already had standard treatment or who are unable to have standard treatment. Standard treatment is the most commonly used treatment for a particular cancer.

People in this trial need to have a type of head and neck cancer that started in the squamous cells. And the cancer either needs to be locally advanced or to have come back after previous treatment.

Recruitment start: 5 June 2015

Recruitment end: 15 October 2024